A 47-year-old man with metabolic syndrome is found to have elevated liver enzymes. Ultrasound shows hepatic steatosis without focal lesions. Hepatitis B and C serology are negative. He drinks minimal alcohol. What is the most important initial management strategy for his presumed non-alcoholic fatty liver disease (NAFLD)?